Form 8-K - Current report:
SEC Accession No. 0001213900-24-078549
Filing Date
2024-09-13
Accepted
2024-09-13 16:02:39
Documents
20
Period of Report
2024-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0214439-8k_oruka.htm   iXBRL 8-K 65867
2 CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A NO ea021443901ex3-1_oruka.htm EX-3.1 99519
3 FORM OF PRE-FUNDED WARRANT ea021443901ex4-1_oruka.htm EX-4.1 76835
4 SECURITIES PURCHASE AGREEMENT, DATED SEPTEMBER 11, 2024, BY AND BETWEEN ORUKA TH ea021443901ex10-1_oruka.htm EX-10.1 410039
5 FORM OF REGISTRATION RIGHTS AGREEMENT ea021443901ex10-2_oruka.htm EX-10.2 109980
6 PRESS RELEASE, DATED SEPTEMBER 11, 2024 ea021443901ex99-1_oruka.htm EX-99.1 15032
7 PRESS RELEASE, DATED SEPTEMBER 11, 2024 ea021443901ex99-2_oruka.htm EX-99.2 12896
8 GRAPHIC ex99-1_001.jpg GRAPHIC 10009
  Complete submission text file 0001213900-24-078549.txt   1132194

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE orka-20240911.xsd EX-101.SCH 3012
10 XBRL LABEL FILE orka-20240911_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE orka-20240911_pre.xml EX-101.PRE 22357
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0214439-8k_oruka_htm.xml XML 3795
Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 241297682
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)